I. Expression across cell types
Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| epithelial cell | 3 studies | 28% ± 9% | |
| dendritic cell | 3 studies | 17% ± 2% | |
| transit amplifying cell | 3 studies | 23% ± 4% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| epithelial cell | 3 studies | 28% ± 9% | |
| dendritic cell | 3 studies | 17% ± 2% | |
| transit amplifying cell | 3 studies | 23% ± 4% |
Insufficient scRNA-seq data for expression of FN3KRP at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| brain | 100% | 2686.10 | 2642 / 2642 | 100% | 69.30 | 705 / 705 |
| prostate | 100% | 1875.93 | 245 / 245 | 100% | 48.98 | 502 / 502 |
| skin | 100% | 2125.91 | 1809 / 1809 | 100% | 64.48 | 472 / 472 |
| thymus | 100% | 1678.52 | 653 / 653 | 100% | 49.24 | 604 / 605 |
| uterus | 100% | 2118.34 | 170 / 170 | 100% | 73.35 | 458 / 459 |
| kidney | 100% | 1785.18 | 89 / 89 | 100% | 49.00 | 898 / 901 |
| lung | 100% | 1565.68 | 578 / 578 | 100% | 52.31 | 1151 / 1155 |
| breast | 100% | 1938.59 | 459 / 459 | 100% | 62.11 | 1113 / 1118 |
| ovary | 100% | 2878.54 | 180 / 180 | 100% | 34.24 | 428 / 430 |
| esophagus | 100% | 1773.34 | 1445 / 1445 | 99% | 27.97 | 182 / 183 |
| liver | 100% | 1183.39 | 226 / 226 | 99% | 43.50 | 402 / 406 |
| bladder | 100% | 1810.24 | 21 / 21 | 99% | 51.33 | 499 / 504 |
| stomach | 100% | 1474.08 | 359 / 359 | 99% | 37.17 | 283 / 286 |
| intestine | 100% | 2008.21 | 966 / 966 | 99% | 44.38 | 521 / 527 |
| pancreas | 99% | 931.31 | 326 / 328 | 99% | 41.30 | 177 / 178 |
| adrenal gland | 100% | 1889.22 | 258 / 258 | 98% | 44.71 | 225 / 230 |
| adipose | 100% | 1739.90 | 1204 / 1204 | 0% | 0 | 0 / 0 |
| blood vessel | 100% | 1972.33 | 1335 / 1335 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 100% | 53.73 | 80 / 80 |
| lymph node | 0% | 0 | 0 / 0 | 100% | 39.48 | 29 / 29 |
| spleen | 100% | 1939.21 | 241 / 241 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 100% | 59.60 | 45 / 45 |
| ureter | 0% | 0 | 0 / 0 | 100% | 34.53 | 1 / 1 |
| heart | 97% | 862.14 | 837 / 861 | 0% | 0 | 0 / 0 |
| muscle | 94% | 607.38 | 756 / 803 | 0% | 0 | 0 / 0 |
| peripheral blood | 74% | 881.44 | 690 / 929 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0043687 | Biological process | post-translational protein modification |
| GO_0005829 | Cellular component | cytosol |
| GO_0102193 | Molecular function | protein-ribulosamine 3-kinase activity |
| GO_0005524 | Molecular function | ATP binding |
| GO_0016301 | Molecular function | kinase activity |
| Gene name | FN3KRP |
| Protein name | protein-ribulosamine 3-kinase (EC 2.7.1.172) Fructosamine 3 kinase related protein Ketosamine-3-kinase (EC 2.7.1.172) (Fructosamine-3-kinase-related protein) (FN3K-RP) (FN3K-related protein) (Protein-psicosamine 3-kinase FN3KRP) (EC 2.7.1.-) |
| Synonyms | hCG_1725347 |
| Description | FUNCTION: Ketosamine-3-kinase involved in protein deglycation by mediating phosphorylation of ribuloselysine and psicoselysine on glycated proteins, to generate ribuloselysine-3 phosphate and psicoselysine-3 phosphate, respectively . Ribuloselysine-3 phosphate and psicoselysine-3 phosphate adducts are unstable and decompose under physiological conditions . Not able to phosphorylate fructoselysine . . |
| Accessions | ENST00000574206.5 A0A140VK84 I3L2G3 ENST00000573158.5 ENST00000574356.5 I3L2K8 ENST00000574832.5 I3L407 Q9HA64 I3L378 Q6FIG5 I3L139 ENST00000571594.1 ENST00000577128.1 ENST00000269373.11 I3L3W5 |
